PDL1
Showing 1 - 25 of 745
PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact
Not yet recruiting
- PDL1- Colorectal Carcinoma
- (no location specified)
Jan 11, 2023
Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT
Recruiting
- Lung Cancer Stage III
- Lung Cancer Stage IV
-
Brest, FranceChu Brest
Aug 16, 2023
HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With
Not yet recruiting
- Gastric Cancer
- Observational
- (no location specified)
Dec 13, 2022
Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)
Not yet recruiting
- Multiple Myeloma
- Bone marow biopsy and aspiration
- biochemical and heamatological tests
- (no location specified)
Aug 9, 2023
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- +4 more
- MK-2870
- +2 more
- (no location specified)
Sep 15, 2023
Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)
Recruiting
- Solid Tumor Malignancy
- +4 more
- mRNA-1273
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC
Recruiting
- Non-small Cell Lung Cancer
-
Monza, ItalyASST-Monza Ospedale San Gerardo
Jun 9, 2022
Advanced Gastroesophageal Adenocarcinoma, First-line Therapy, PDL1 CPS < 5 Trial (CAPOX combined with bevacizumab and
Not yet recruiting
- Advanced Gastroesophageal Adenocarcinoma
- +2 more
- CAPOX combined with bevacizumab and Tislelizumab
- (no location specified)
Mar 17, 2022
Acute Lymphoblastic Leukemia in Pediatric Trial in Sohag (flow cytometric immunophynotyping)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Pediatric
- flow cytometric immunophynotyping
-
Sohag, EgyptSohag University Hospital
Jun 19, 2022
Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
- camrelizumab for Injection
- (no location specified)
Nov 13, 2023
Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)
Not yet recruiting
- Cervical Cancer
- Recombinant humanized anti-PD-1 monoclonal antibody injection
- +4 more
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023
SOX2 & PDL1 Expression on Urinary Bladder Carcinoma
Not yet recruiting
- Urinary Bladder Neoplasm
- (no location specified)
Jun 17, 2022
Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
Recruiting
- Sarcoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
-
Beijing, ChinaPeking University People's Hospital
Nov 6, 2023
Locally Advanced or Metastatic Solid Tumors, NSCLC Trial in Australia (HLX301)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- Non-small Cell Lung Cancer
-
Blacktown, New South Wales, Australia
- +4 more
May 25, 2022
Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)
Not yet recruiting
- Chemotherapy
- Radiation Therapy
- Camrelizumab
- +3 more
-
Fuzhou, ChinaFujian Medical University Union Hospital
Apr 6, 2023
Urothelial Carcinoma Trial in Ann Arbor (Pembrolizumab, Abraxane)
Active, not recruiting
- Urothelial Carcinoma
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 15, 2021
Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab
Recruiting
- Metastatic Gastric Cancer
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
- Nivolumab Injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Aug 23, 2023
Cancer Trial in Besancon (Biological samples, Anti PD1/PDL1 treatment)
Recruiting
- Cancer
- Biological samples
- Anti PD1/PDL1 treatment
-
Besancon, FranceUniversity Hospital of Besançon
Jul 30, 2021
Lung Cancer Trial in Assiut (Observational Study ( Tissue Biopsy ))
Completed
- Lung Cancer
- Observational Study ( Tissue Biopsy )
-
Assiut, EgyptAssiut University
Oct 18, 2021
SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)
Not yet recruiting
- SCLC,Extensive Stage
- AK104 IV infusion;Chiauranib oral
-
Changchun, Jilin, ChinaJilin Province Cancer Hospital
Aug 16, 2022